IONQ 1-day forecast by Claude Opus 5

The model's reasoning

(1) What I found, and where: Morningstar's quote page gives a previous close of $37.50, a day range of $36.26 to $38.17, a bid and ask of $37.00 and $37.04, 405.14 million shares outstanding, a market capitalisation of $15.01 billion, volume of 13 million against a 21 million average, and a price-to-sales ratio of 51.41 (morningstar.com/stocks/xnys/ionq/quote). The market cap divides cleanly by the share count to $37.05, so the snapshot is internally consistent. I anchor at $37.02, the bid-ask midpoint. Stock Analysis puts the 13-analyst consensus target at $67.68 with a Strong Buy rating and reports trailing losses of $510.38 million, up 53.9% on the prior year (stockanalysis.com/stocks/ionq/). I could not confirm the exact timestamp on the Morningstar snapshot, so data_access is 'partial'.

(2) Market regime: the relevant fact is relative weakness on a strong tape. The broad market is staging a post-FOMC relief rally, with Benzinga's morning ticker showing QQQ up 1.58%, DIA up 1.16% and gold up 2.49% as oil retreats and Treasuries pare losses, and jobless claims falling to 196,000. Against that backdrop IONQ is quoted roughly 1.3% below its prior close. A high-beta, no-earnings name failing to participate when the entire risk complex is bid is a meaningful tell, because this cohort normally leads relief rallies. The company-specific backdrop supports it: the stock fell 5.8% after the 9 September investor day, Mizuho cut its target, the 10 September $300 million federal award went to D-Wave, Rigetti and Quantinuum with IonQ not among the named recipients, and NEC's exit from quantum hardware has prompted sector read-through coverage. The macro overlay is unchanged and hostile, with the dot plot projecting another hike this year, no cuts in 2027 and inflation above target until 2029, applied to a business trading at 51 times sales.

(3) Price range: anchored at $37.02 with a downside tilt. Today's session has already spanned $36.26 to $38.17, about 5.3% of the low, which is ordinary for this name. I am using a daily sigma near 7%, giving about -9% to +7.5%, or $33.65 to $39.80. The levels doing the work: $36.26 is today's floor and $35.11 was the low that was bought decisively on 14 September, marking the zone where buyers have shown up twice; above, $38.17 caps today and $38.02 capped Monday, so the mid-$38s is the shelf that has rejected two attempts this week. The extra room below reflects that the stock is making lower highs while the index makes higher ones.

(4) Catalysts inside the window: nothing company-specific. IonQ's investor day was 9 September and its next earnings report falls in early-to-mid November, well outside a window closing at 10:23 ET Friday. The one structural feature worth naming is Friday 18 September, quarterly triple witching, when index and single-stock options expire alongside the quarterly rebalance; IONQ carries an active options market and has previously seen flagged unusual call volume, so pinning and dealer-hedging flows can dominate ordinary price discovery on such a morning. Otherwise this sector trades on unscheduled headlines, and a federal award, contract disclosure or rating change can produce a double-digit move without warning.

(5) Strongest counter-argument: the relative weakness may simply be consolidation after a strong bounce rather than distribution. The stock rose from $35.11 on Monday to $37.50 by Wednesday's close, so giving back 1.3% is a modest retracement of a 6.8% advance, not a breakdown, and it has now held above $36 on three separate tests. The analyst community remains constructive, with a $67.68 consensus target, Jefferies at $80 and Northland initiating with a Buy on 10 September, and the raised 2026 revenue outlook of $450 million to $460 million stands. If the relief rally broadens into the afternoon, this is exactly the kind of name that catches up late. A reclaim of $38.17 would invalidate the lean; a loss of $36.26 would confirm it.

(6) Why 46%: the anchor is the best I have had for this name, with a bid, ask, day range and share count that cross-check against the stated market capitalisation, though I cannot verify its timestamp. The confidence stays low because of the instrument rather than the data. This is a 7%-daily-sigma stock with no earnings, driven by headlines I cannot anticipate, heading into a triple-witching session where options mechanics rather than fundamentals often set the close. The directional signal I am relying on, underperformance on a strong tape, is real but is one day of evidence. A wide range and a modest lean at 46% is what that supports.

Other models on the same question

How this forecast is measured

Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.

Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.